CTVA 10-Q Quarterly Reports

Corteva, Inc. reported a net loss of $320 million, or $0.47 per share, for the third quarter of 2025, a significant improvement from the prior year's loss of $524 million, or $0.76 per share. This turn-around was driven by a substantial increase in net sales, which grew 13% to $2.62 billion, fueled by a 12% volume increase and a favorable 2% currency impact, partially offset by a 1% price decline. The company's Seed segment showed particular strength, with net sales up 33% driven by early deliveries in Brazil and recovery in Argentina, while the Crop Protection segment also saw a 4% increase in net sales due to demand for new products. For the nine-month period, net sales increased by 4% to $13.49 billion, with net income reaching $1.65 billion, a significant improvement from $958 million in the prior year. This performance reflects strategic execution in both segments, with the Seed segment benefiting from strong pricing and volume growth and the Crop Protection segment seeing benefits from raw material deflation and productivity savings. The company also announced its intent to separate into two independent publicly traded companies, one focused on seeds and the other on crop protection, a move expected to unlock further value.

Corteva, Inc. reported a strong second quarter and first half of 2025, with net sales increasing by 6% and 3% respectively, driven by volume growth and price increases across both its Seed and Crop Protection segments. The company demonstrated improved profitability, with net income rising significantly compared to the prior year, reflecting effective cost management and productivity initiatives. Operating EBITDA also saw substantial year-over-year growth, underscoring operational efficiencies and strong market performance, particularly in North America. Corteva continues to return value to shareholders through share repurchases and dividends, and is actively managing its operational footprint with ongoing restructuring efforts in its Crop Protection segment expected to yield significant savings. While the company experienced some unfavorable currency impacts, its diverse geographic presence and product portfolio helped mitigate these effects. Corteva remains focused on innovation and strategic investments in research and development to support its long-term growth. The company's financial position appears robust, with ample liquidity and access to credit facilities to fund its operations and strategic initiatives. Investors will be closely monitoring the progress of the Crop Protection restructuring and the ongoing legal and environmental matters, which, while managed, represent potential areas of future impact.

Corteva, Inc. reported a net income of $656 million for the first quarter of 2025, a significant increase from $423 million in the same period of the prior year. This improvement was driven by higher income from continuing operations, which rose to $667 million from $376 million. Diluted earnings per share also saw a substantial increase, reaching $0.95 compared to $0.60 year-over-year. Net sales for the quarter were $4,417 million, a slight decrease of 2% compared to $4,492 million in Q1 2024. This was primarily due to a 5% unfavorable currency impact, partially offset by a 2% increase in volume and a 1% increase in price. The company continues to navigate global economic conditions, including currency fluctuations, while focusing on operational efficiencies and strategic pricing. The company also returned approximately $385 million to shareholders through share repurchases and dividends.

Corteva, Inc. reported net sales of $2,326 million for the third quarter of 2024, a decrease of 10% compared to the same period in the prior year, primarily driven by an 8% decrease in price and a 5% unfavorable currency impact, partially offset by a 3% increase in volume. The company experienced a net loss of $521 million for the quarter, compared to a net loss of $318 million in the prior year quarter. For the first nine months of 2024, net sales decreased by 4% to $12,930 million, with a net income of $948 million compared to $988 million in the same period last year. The company is navigating a competitive pricing environment in Crop Protection, particularly in Latin America, and reduced corn planted area in Argentina impacted Seed volumes. Despite these challenges, Corteva continues to invest in R&D and is implementing cost and productivity initiatives. The company also announced a restructuring program for its Crop Protection network, expected to yield significant savings by 2027. Corteva's outlook for full-year 2024 anticipates net sales between $17.0 billion and $17.2 billion, with Operating EBITDA expected to be between $3.35 billion and $3.45 billion. The company remains committed to returning capital to shareholders through dividends and share repurchases.

Corteva, Inc. reported solid results for the second quarter of 2024, demonstrating resilience and strategic execution. Net sales increased by 1% year-over-year to $6.112 billion, driven by a 2% price increase that offset a 1% unfavorable impact from portfolio and other changes, while volumes remained flat overall. The Seed segment showed particular strength, with net sales up 2% driven by strong pricing and a favorable product mix, contributing significantly to a 16% increase in segment operating EBITDA. This segment is outperforming the market and gaining share, underscoring the value of its advanced germplasm and trait technologies. While the Crop Protection segment's net sales were flat year-over-year, driven by increased volumes in certain areas offset by price declines and currency headwinds, its segment operating EBITDA decreased by 20%. This was attributed to competitive pricing and raw material cost inflation, despite productivity savings and volume growth. The company continues to navigate a challenging market environment in Crop Protection but expects elevated input costs to subside in the second half of 2024. Overall, Corteva reiterated its full-year 2024 outlook for net sales and Operating EBITDA, signaling confidence in its strategic direction and operational capabilities.

Corteva, Inc. reported first quarter 2024 net sales of $4,492 million, a decrease of 8% compared to the prior year, primarily driven by a 9% decrease in volume, partially offset by a 3% increase in price. Net income attributable to Corteva was $419 million, or $0.60 per share, down from $595 million, or $0.84 per share, in the first quarter of 2023. The decline in earnings was influenced by lower sales volumes, increased R&D expenses, and higher restructuring charges related to the Crop Protection Operations Strategy Restructuring Program. The company is reaffirming its full-year 2024 outlook, expecting net sales between $17.4 billion and $17.7 billion and Operating EBITDA between $3.5 billion and $3.7 billion. Despite the year-over-year decline in the first quarter, management anticipates market growth in the second half of 2024, particularly in the Crop Protection segment, and continues to focus on cost and productivity improvements. Corteva also returned approximately $365 million to shareholders through share repurchases and dividends in the first quarter.

Corteva, Inc. reported a net sales decline of 7% for the third quarter of 2023 compared to the prior year, driven primarily by a 15% decrease in volume, though partially offset by price increases and favorable currency impacts. For the first nine months of the year, net sales saw a slight decrease of 1%, also primarily due to lower volumes which were impacted by strategic product exits, inventory destocking, and delayed farmer purchases. The company has been investing in research and development, with an increase in R&D expenses year-over-year to support long-term growth. Significant progress has been made integrating the Stoller and Symborg acquisitions, which supplement the crop protection business with biological tools. Despite the sales volume challenges, Corteva's financial performance was supported by pricing strategies and cost management initiatives. The company is also actively managing its capital structure, including share repurchases and dividend payments.

Corteva, Inc. reported net sales of $6.045 billion for the second quarter of 2023, a 3% decrease compared to the prior year, primarily driven by a 13% volume decline, partially offset by a 9% increase in price. The six-month period showed a 1% increase in net sales to $10.929 billion, with an 11% price increase offsetting a 9% volume decline. Net income for the quarter was $714 million ($1.00 per diluted share), down from $969 million ($1.33 per diluted share) in the same period last year. The company completed significant acquisitions of Stoller and Symborg in March 2023, integrating biological and microbiological technologies into its crop protection portfolio. Despite overall sales challenges, the company highlighted strong price execution and ongoing cost and productivity initiatives, while also managing increased interest expenses and investing in R&D.

Corteva, Inc. reported a net sales increase of 6% to $4.88 billion for the first quarter of 2023, driven by a 14% price increase, partially offset by a 4% volume decrease and a 5% unfavorable currency impact. Net income increased to $595 million, or $0.83 per diluted share, compared to $564 million, or $0.78 per diluted share, in the prior year's quarter. The company completed significant acquisitions of Stoller Group, Inc. and Quorum Vital Investment, S.L. (Symborg) for a combined $1.6 billion, strengthening its biologicals and microbiological technologies portfolio. Corteva also updated its full-year 2023 guidance, raising its net sales and Operating EBITDA expectations to reflect the impact of these acquisitions.

Corteva, Inc. (CTVA) reported a strong increase in net sales for the third quarter and the first nine months of 2022, driven by significant price increases and volume growth across both its Seed and Crop Protection segments. Despite these top-line gains, the company experienced a net loss in the third quarter, primarily due to substantial restructuring and asset-related charges, including costs associated with exiting Russia. For the nine-month period, net income was lower year-over-year, also impacted by these charges. The company affirmed its full-year net sales outlook and increased its Operating EBITDA guidance, signaling confidence in its operational performance and market position despite macroeconomic headwinds and inflationary pressures.

Corteva, Inc. reported strong performance for the second quarter and first half of 2022, with net sales increasing by 11% year-over-year for both periods. This growth was driven by a robust increase in pricing (9%) and volume (4% and 5% respectively), indicating effective execution of its "price for value" strategy and successful new product introductions. Despite facing headwinds from unfavorable currency impacts, particularly from the Turkish Lira and Euro, and rising input costs, the company demonstrated resilience through ongoing cost and productivity initiatives. The company's Seed segment saw a 4% increase in net sales for Q2, driven by strong pricing, while the Crop Protection segment experienced significant growth of 25% due to higher volumes and pricing. This strong operational performance translated into improved profitability, with Segment Operating EBITDA increasing significantly in both segments, especially in Crop Protection. Corteva also reiterated its positive outlook for the full year 2022, increasing its net sales and Operating EBITDA guidance, reflecting confidence in its strategic direction and market position.

Corteva, Inc. reported a solid first quarter for 2022, with net sales increasing by 10% year-over-year to $4.6 billion. This growth was primarily driven by a 9% increase in price and a 7% rise in volume, reflecting strong demand and successful pricing strategies, although partially offset by a 6% unfavorable currency impact. The company's operating EBITDA also saw a significant improvement, up 15% to $1.04 billion, demonstrating effective cost management and strong sales execution across all regions, despite inflationary pressures on input and logistics costs. The company continues to return capital to shareholders, repurchasing approximately $335 million in common stock and paying dividends in the first quarter. Corteva is affirming its full-year 2022 outlook for net sales and Operating EBITDA, indicating confidence in continued performance. However, investors should note the ongoing global economic uncertainties, including the conflict in Ukraine and associated sanctions, which have led Corteva to announce its withdrawal from Russia, expecting related charges. The company also faces ongoing litigation and environmental matters, which, while managed, represent potential contingent liabilities.

Corteva, Inc. (CTVA) reported a significant turnaround in its third quarter of 2021 compared to the same period in 2020, demonstrating strong top-line growth and improved profitability. Net sales surged by 27% year-over-year, driven by a robust 17% increase in volume and a 7% price increase, reflecting successful new technology adoption and effective pricing strategies across its Seed and Crop Protection segments. The company's Operating EBITDA also saw substantial improvement, turning positive and indicating effective cost management amidst inflationary pressures. For the nine-month period, Corteva continued its positive momentum with an 11% increase in net sales, driven by solid volume and price gains. The company successfully navigated cost headwinds, such as higher input and logistics expenses, through ongoing productivity initiatives and favorable currency impacts. Corteva also reaffirmed its full-year 2021 outlook for net sales and operating earnings per share, signaling confidence in its continued performance. The company also returned significant capital to shareholders through share repurchases and dividends.

Corteva, Inc. reported strong financial results for the second quarter and first half of 2021, demonstrating robust top-line growth and improved profitability. Net sales increased by 8% in the second quarter and 7% for the first half, driven by volume increases across both the Seed and Crop Protection segments. This growth was supported by a 5% volume increase in Q2 and 4% in H1, along with favorable currency impacts and modest price increases. The company also saw a significant improvement in profitability, with income from continuing operations after income taxes rising to $1,018 million in Q2 2021 and $1,631 million in H1 2021, compared to $766 million and $1,047 million respectively in the prior year periods. This profitability enhancement was driven by strong price execution, volume gains, and effective cost and productivity actions, which helped offset increased input costs and logistics challenges. Corteva also continues to actively manage its capital structure and return value to shareholders. The company announced a new $1.5 billion share repurchase program and increased its quarterly dividend. Despite facing inflationary pressures and supply chain constraints, Corteva raised its full-year 2021 outlook, anticipating a 7-8% increase in net sales and significant growth in Operating EBITDA and Operating Earnings Per Share. The company remains focused on innovation and operational efficiency to drive future growth and shareholder returns.

Corteva, Inc. reported a strong first quarter in 2021, with net sales increasing by 6% year-over-year to $4,178 million. This growth was driven by a balanced combination of 3% higher volume and 3% higher prices across both its Seed and Crop Protection segments. The company demonstrated improved profitability, with income from continuing operations after income taxes rising significantly to $613 million from $281 million in the prior year period, and diluted EPS increasing to $0.80 from $0.36. Despite facing increased input costs for raw materials and logistics, Corteva effectively managed these headwinds through strategic pricing and ongoing productivity initiatives, leading to a notable increase in Operating EBITDA. The company also continued its commitment to shareholder returns, repurchasing $350 million of its common stock and paying dividends. While global economic recovery and supply chain challenges were noted, Corteva's outlook for 2021 remains positive, with an expected increase in net sales and continued growth in operating metrics.

Corteva, Inc. reported its third quarter and year-to-date financial results for the period ending September 30, 2020. For the three months ended September 30, 2020, net sales were $1,863 million, a decrease of 3% year-over-year, primarily due to currency headwinds and a slight portfolio impact, partially offset by volume and price increases. The company reported a net loss of $390 million for the quarter, an improvement from a loss of $505 million in the same period last year. For the nine months ended September 30, 2020, net sales increased by 1% to $11,010 million, with a net income of $658 million, a significant improvement from a net loss of $923 million in the prior year period. The company's performance was influenced by ongoing cost synergies, productivity efforts, and a strategic focus on new product adoption, despite challenges from currency fluctuations and global economic uncertainty related to COVID-19. The company continued to manage its operations effectively amidst the ongoing COVID-19 pandemic, which was identified as an "essential business" sector. Corteva maintained its business operations without material impact on financial results, though localized disruptions in sourcing and logistics were experienced. The company also provided an updated outlook for the full year 2020, expecting a net sales increase of approximately 1-2% and Operating EBITDA to be down 4% to up 1% compared to 2019, reflecting continued currency headwinds and economic volatility. Significant investments in new product development within the crop protection segment were noted, contributing to volume gains.

Corteva, Inc. reported a solid second quarter for 2020, demonstrating resilience in a challenging economic environment. Net sales for the quarter were $5.19 billion, a decrease of 7% year-over-year, primarily driven by lower volumes, which were impacted by earlier than usual deliveries in North America and a normalized start to the season in Latin America. However, this was partially offset by a 1% increase in price and ongoing cost synergies. For the first six months of 2020, net sales increased by 2% to $9.15 billion, driven by a 4% increase in volume and a 1% increase in local price, despite a 3% negative currency impact. The company's focus on operational efficiency and cost management, as evidenced by the "Execute to Win" program, contributed to improved profitability and cash flow from operations compared to the prior year. Despite the ongoing uncertainties related to COVID-19 and market volatility, Corteva maintains a positive outlook, projecting a 1-2% increase in net sales for the full year 2020.

Corteva, Inc. reported a strong first quarter in 2020, with net sales increasing by 16% year-over-year to $3.96 billion. This growth was primarily driven by a significant 17% increase in volume, particularly in the Seed segment, supported by favorable weather conditions and strong demand. The company also benefited from price increases, though partially offset by currency headwinds. Net income attributable to Corteva was $272 million, a substantial improvement from the prior year's comparable period and a significant rebound from the net loss reported in Q1 2019 from continuing operations. This performance was bolstered by the absence of integration and separation costs incurred in the prior year and improved operating leverage. The company also highlighted operational efficiencies and progress on its "Execute to Win" productivity program, positioning it for continued operational improvements.

Corteva, Inc. reported a net sales decline of 2% year-over-year for the third quarter of 2019, reaching $1.91 billion. This decrease was primarily driven by unfavorable currency movements and a slight decline in pricing, although volume saw a modest increase. The company reported a loss from continuing operations after income taxes of $527 million for the quarter, an improvement from the significant loss of $5,642 million in the prior year period. This improvement is largely attributed to a substantial reduction in goodwill impairment charges and lower operating expenses. For the first nine months of 2019, net sales decreased by 5% to $10.86 billion, also impacted by currency and volume, with a net loss from continuing operations after income taxes of $228 million, significantly better than the $5,705 million loss in the same period of 2018. The company is actively managing its cost structure, realizing cost synergies, and has initiated a $1 billion share repurchase program, demonstrating a focus on shareholder returns amidst ongoing integration and business realignments.

Corteva, Inc. reported its first quarterly report as an independent public company for the period ending June 30, 2019. The company generated net sales of $5.56 billion for the quarter, a slight decrease from the prior year, primarily attributed to weather-related impacts in North America and unfavorable currency movements. Despite the revenue dip, income from continuing operations after taxes increased significantly to $483 million, driven by lower cost of goods sold due to reduced amortization of inventory step-up and a decrease in research and development expenses. The company continues to navigate significant integration and separation costs, which increased year-over-year, reflecting the ongoing efforts post-merger and spin-off. Corteva also announced a $1 billion share repurchase program and a quarterly dividend, signaling confidence in its financial position and commitment to returning value to shareholders. The company's balance sheet reflects substantial debt reduction compared to the previous year, indicating progress in deleveraging.

Corteva, Inc.'s (CTVA) first quarter 2019 report (filed May 30, 2019) highlights a net income of $85 million, a significant improvement from a net loss of $228 million in the prior year's comparable period. This turnaround is largely attributable to substantial restructuring and integration costs in the prior year. Net sales for the quarter were $6.3 billion, a decrease from $6.7 billion in Q1 2018, primarily due to volume declines in agriculture and transportation and advanced polymers, alongside unfavorable currency impacts. The company is in the midst of significant corporate restructuring, preparing for the separation of its agriculture business from DowDuPont, which was expected to be completed on June 1, 2019. This ongoing separation process is reflected in substantial "Integration and separation costs" of $405 million in Q1 2019 compared to $255 million in Q1 2018. Despite the sales decrease and high separation costs, the improved net income signals operational recovery and progress towards a more streamlined, focused entity.